nct_id,nlm_download_date_description,study_first_submitted_date,results_first_submitted_date,disposition_first_submitted_date,last_update_submitted_date,study_first_submitted_qc_date,study_first_posted_date,study_first_posted_date_type,results_first_submitted_qc_date,results_first_posted_date,results_first_posted_date_type,disposition_first_submitted_qc_date,disposition_first_posted_date,disposition_first_posted_date_type,last_update_submitted_qc_date,last_update_posted_date,last_update_posted_date_type,start_month_year,start_date_type,start_date,verification_month_year,verification_date,completion_month_year,completion_date_type,completion_date,primary_completion_month_year,primary_completion_date_type,primary_completion_date,target_duration,study_type,acronym,baseline_population,brief_title,official_title,overall_status,last_known_status,phase,enrollment,enrollment_type,source,limitations_and_caveats,number_of_arms,number_of_groups,why_stopped,has_expanded_access,expanded_access_type_individual,expanded_access_type_intermediate,expanded_access_type_treatment,has_dmc,is_fda_regulated_drug,is_fda_regulated_device,is_unapproved_device,is_ppsd,is_us_export,biospec_retention,biospec_description,ipd_time_frame,ipd_access_criteria,ipd_url,plan_to_share_ipd,plan_to_share_ipd_description,created_at,updated_at,intervention_type,intervention_name,description,intervention_count,status,facility_name,city,state,zip,country,site_count
NCT04245631,"ClinicalTrials.gov processed this data on March 31, 2020",2020-01-26,NA,NA,2020-01-26,2020-01-26,2020-01-29,Actual,NA,NA,NA,NA,NA,NA,2020-01-26,2020-01-29,Actual,"January 1, 2020",Actual,2020-01-01,January 2020,2020-01-31,"December 31, 2020",Anticipated,2020-12-31,"December 31, 2020",Anticipated,2020-12-31,NA,Observational,NA,,"Development of a Simple, Fast and Portable Recombinase Aided Amplification Assay for 2019-nCoV","Development of a Simple, Fast and Portable Recombinase Aided Amplification (RAA) Assay for 2019-nCoV",Recruiting,NA,NA,50,Anticipated,Beijing Ditan Hospital,,NA,1,NA,FALSE,NA,NA,NA,NA,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-04-01T09:28:14Z,2020-04-01T09:28:14Z,Diagnostic Test,Recombinase aided amplification (RAA) assay,"We established a real time reverse-transcription RAA (RT-RAA) assay for detection of 2019-nCoV. This assay was performed at 42Â°C within 30min using a portable real-time fluorescence detector, Recombinant plasmids containing conserved ORF1ab genes was used to analyze the specificity and sensitivity. Clinical specimens from patients who were suspected of being infected with 2019-nCoV were used to evaluate the performance of the assay. In parallel, we also used the commercial RT-qPCR assay kit for 2019-nCoV as a reference. Sample types include either of nasal swab, oral swab, bronchoalveolar-lavage fluid, urea, blood, fecal.",1,Recruiting,"Department of Hepatology Division 2, Beijing Ditan Hospital",Beijing,Beijing,100015,China,1
NCT04256395,"ClinicalTrials.gov processed this data on March 31, 2020",2020-02-01,NA,NA,2020-02-18,2020-02-03,2020-02-05,Actual,NA,NA,NA,NA,NA,NA,2020-02-18,2020-02-20,Actual,"February 1, 2020",Actual,2020-02-01,February 2020,2020-02-29,"July 31, 2020",Anticipated,2020-07-31,"July 31, 2020",Anticipated,2020-07-31,NA,Observational,COVID-19,,Efficacy of a Self-test and Self-alert Mobile Applet in Detecting Susceptible Infection of COVID-19,Registry Study on the Efficacy of a Self-test and Self-alert Applet in Detecting Susceptible Infection of COVID-19 â€”â€”a Population Based Mobile Internet Survey,Recruiting,NA,NA,300000,Anticipated,Beijing Tsinghua Chang Gung Hospital,,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-04-01T09:26:48Z,2020-04-01T09:26:48Z,Other,mobile internet survey on self-test,"1. make a questionnaire, the content of which refers to the new coronavirus diagnosis and treatment guidelines released by the National Health Commission; 2. develop the mobile applet and carry out internet propagation; 3. background data could be identified according to computer technology, de duplication and de privacy; 4. once registered, the applet can automatically remind the self-test twice a day, and encourage to adhere to 14 days; 5. automatically compare with the standards and highly suspected population could be given medical guidance and encouraged to go to the fever clinic of the designated hospital for definite diagnosis.",1,Recruiting,Beijing Tsinghua Changgung Hospital,Beijing,Beijing,102218,China,1
NCT04260308,"ClinicalTrials.gov processed this data on March 31, 2020",2020-02-03,NA,NA,2020-02-05,2020-02-05,2020-02-07,Actual,NA,NA,NA,NA,NA,NA,2020-02-05,2020-02-07,Actual,"February 3, 2020",Actual,2020-02-03,February 2020,2020-02-29,"April 20, 2020",Anticipated,2020-04-20,"April 15, 2020",Anticipated,2020-04-15,NA,Observational,NA,,A Survey of Psychological Status of Medical Workers and Residents in the Context of 2019 Novel Coronavirus Pneumonia,"A Survey of Psychological Status of Medical Workers and Residents in the Context of 2019 Novel Coronavirus Pneumonia in Wuhan, China",Recruiting,NA,NA,30000,Anticipated,Huazhong University of Science and Technology,,NA,2,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-04-01T09:26:18Z,2020-04-01T09:26:18Z,NA,NA,NA,NA,Recruiting,Tongji Hospitalï¼ŒTongji Medical College Affiliatedï¼ŒHuazhong University of Science ï¼† Technology,Wuhan,Hubei,430030,China,1
NCT04255940,"ClinicalTrials.gov processed this data on March 31, 2020",2020-02-03,NA,NA,2020-02-03,2020-02-03,2020-02-05,Actual,NA,NA,NA,NA,NA,NA,2020-02-03,2020-02-05,Actual,"January 20, 2020",Actual,2020-01-20,February 2020,2020-02-29,"April 30, 2020",Anticipated,2020-04-30,"April 30, 2020",Anticipated,2020-04-30,NA,Observational,NA,,2019-nCoV Outbreak and Cardiovascular Diseases,Impact of a Novel Coronavirus (2019-nCoV) Outbreak on Public Anxiety and Cardiovascular Disease Risk in China,Recruiting,NA,NA,12000,Anticipated,Qilu Hospital of Shandong University,,NA,3,NA,FALSE,NA,NA,NA,NA,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-04-01T09:26:53Z,2020-04-01T09:26:53Z,NA,NA,NA,NA,Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting,"Affiliated Hospital of Binzhou Medical Universty|Heze Municipal Hospital|Shandong University Qilu Hospital|Jinan Central Hospital, Shandong University|First Hospital Affiliated with Shandong First Medical University|Shandong Provincial Hospital, Shandong University|The Second Hospital of Shandong University|Jining Hospital of Traditional Chinese Medicine|Qihe People's Hospital|Affiliated Hospital of Qingdao University Medical College|Weihai Municipal Hospital|Central Hospital of Zibo",Binzhou|Heze|Jinan|Jinan|Jinan|Jinan|Jinan|Jining|Qihe|Qingdao|Weihai|Zibo,Shandong|Shandong|Shandong|Shandong|Shandong|Shandong|Shandong|Shandong|Shandong|Shandong|Shandong|Shandong,||250012|250013|250014|250021||||266003||,China|China|China|China|China|China|China|China|China|China|China|China,12
NCT04259892,"ClinicalTrials.gov processed this data on March 31, 2020",2020-02-05,NA,NA,2020-02-13,2020-02-05,2020-02-07,Actual,NA,NA,NA,NA,NA,NA,2020-02-13,2020-02-17,Actual,"February 4, 2020",Actual,2020-02-04,February 2020,2020-02-29,"February 4, 2021",Anticipated,2021-02-04,"October 4, 2020",Anticipated,2020-10-04,NA,Observational,Cov-CONTACT,,Viral Excretion in Contact Subjects at High/Moderate Risk of Coronavirus 2019-nCoV Infection,Viral Excretion in Contact Subjects at High/Moderate Risk of Coronavirus 2019-nCoV Infection,Recruiting,NA,NA,300,Anticipated,"Institut National de la SantÃ© Et de la Recherche MÃ©dicale, France",,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,Samples Without DNA,"
      Nasopharyngeal swabs
    ",NA,NA,NA,Undecided,NA,2020-04-01T09:26:21Z,2020-04-01T09:26:21Z,Biological,2019-nCoV PCR,Nasopharyngeal swabs,1,Recruiting,CIC 1425,Paris,,75018,France,1
NCT04270383,"ClinicalTrials.gov processed this data on March 31, 2020",2020-02-11,NA,NA,2020-02-14,2020-02-13,2020-02-17,Actual,NA,NA,NA,NA,NA,NA,2020-02-14,2020-02-17,Actual,"February 15, 2020",Anticipated,2020-02-15,February 2020,2020-02-29,"December 31, 2020",Anticipated,2020-12-31,"December 31, 2020",Anticipated,2020-12-31,NA,Observational,NA,,Clinical Characteristics and Long-term Prognosis of 2019-nCoV Infection in Children,A Multicenter Observational Study About the Clinical Characteristics and Long-term Prognosis of 2019-nCoV Infection in Children,Not yet recruiting,NA,NA,500,Anticipated,Beijing Children's Hospital,,NA,2,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,Samples Without DNA,"
      Serum
    ",NA,NA,NA,Undecided,NA,2020-04-01T09:24:56Z,2020-04-01T09:24:56Z,NA,NA,NA,NA,,"Beijing Children's Hospital,",Beijing,,,China,1
NCT04272710,"ClinicalTrials.gov processed this data on March 31, 2020",2020-02-12,NA,NA,2020-03-13,2020-02-14,2020-02-17,Actual,NA,NA,NA,NA,NA,NA,2020-03-13,2020-03-17,Actual,"January 25, 2020",Actual,2020-01-25,March 2020,2020-03-31,"April 30, 2020",Anticipated,2020-04-30,"March 31, 2020",Anticipated,2020-03-31,NA,Observational,NA,,Prognositc Factors in COVID-19 Patients Complicated With Hypertension,Prognostic Characteristics Difference Between the Hypertension Patients With and Without ACEI Treatment When Suffered With 2019-nCoV Infection in China,Withdrawn,NA,NA,0,Actual,Chongqing Medical University,,NA,2,"Similar projects have been registered, and it need to be withdrawn.",FALSE,NA,NA,NA,NA,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-04-01T09:24:34Z,2020-04-01T09:24:34Z,NA,NA,NA,NA,,The First Affiliated Hospital of Chongqing Medical University,Chongqing,,,China,1
NCT04283396,"ClinicalTrials.gov processed this data on March 31, 2020",2020-02-13,NA,NA,2020-03-15,2020-02-20,2020-02-25,Actual,NA,NA,NA,NA,NA,NA,2020-03-15,2020-03-17,Actual,"February 21, 2020",Actual,2020-02-21,March 2020,2020-03-31,"July 30, 2020",Anticipated,2020-07-30,"May 30, 2020",Anticipated,2020-05-30,NA,Observational,NA,,Study for Novel Coronavirus Pneumonia (NCP),Study for Clinical Epidemiology and Methods of Diagnosis and Treatment of Novel Coronavirus Pneumonia (NCP),Recruiting,NA,NA,2000,Anticipated,"Wuhan Union Hospital, China",,NA,NA,NA,FALSE,NA,NA,NA,NA,TRUE,TRUE,NA,NA,NA,NA,,NA,NA,NA,Undecided,NA,2020-04-01T09:23:13Z,2020-04-01T09:23:13Z,Combination Product,systemic treatment,"Oxygen therapy, antiviral therapy, antibiotics, hormones, globulin",1,Recruiting,Union hospital,Wuhan,Hubei,430000,China,1
NCT04279782,"ClinicalTrials.gov processed this data on March 31, 2020",2020-02-15,NA,NA,2020-02-20,2020-02-19,2020-02-21,Actual,NA,NA,NA,NA,NA,NA,2020-02-20,2020-02-24,Actual,"January 20, 2020",Actual,2020-01-20,February 2020,2020-02-29,"February 28, 2021",Anticipated,2021-02-28,"January 31, 2021",Anticipated,2021-01-31,NA,Observational,NA,,Clinical Features of Suspected and Confirmed Patients of 2019 Novel Coronavirus Infection,Investigation on Clinical Features of Suspected and Confirmed Patients of 2019 Novel Coronavirus Infection in Isolation Unit,Recruiting,NA,NA,100,Anticipated,"Third Affiliated Hospital, Sun Yat-Sen University",,NA,2,NA,FALSE,NA,NA,NA,NA,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,NA,2020-04-01T09:23:39Z,2020-04-01T09:23:39Z,Other,Comprehensive treatment,"Comprehensive treatment includes antiviral therapy, antibiotics therapy, symptomatic treatment, supportive therapy.",1,Recruiting,The Third Affiliated Hospital of Sun Yat-sen University,Guangzhou,Guangdong,510630,China,1
NCT04274322,"ClinicalTrials.gov processed this data on March 31, 2020",2020-02-16,NA,NA,2020-02-16,2020-02-16,2020-02-18,Actual,NA,NA,NA,NA,NA,NA,2020-02-16,2020-02-18,Actual,February 2020,Anticipated,2020-02-29,February 2020,2020-02-29,July 2020,Anticipated,2020-07-31,May 2020,Anticipated,2020-05-31,NA,Observational,NA,,Identifying Critically-ill Patients With COVID-19 Who Will Benefit Most From Nutrition Support Therapy: Validation of the NUTRIC Nutritional Risk Assessment Tool,Identifying Critically-ill Patients With COVID-19 Who Will Benefit Most From Nutrition Support Therapy: Validation of the NUTRIC Nutritional Risk Assessment Tool (COV_NUTRIC),Not yet recruiting,NA,NA,100,Anticipated,Peking University Third Hospital,,NA,2,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-04-01T09:24:21Z,2020-04-01T09:24:21Z,Other,Nutrition support,"Calories and proteins are given to patients by using ways as parenteral nutriton, enteral nutrition, oral nutrition supplement",1,NA,NA,NA,NA,NA,NA,NA
NCT04275947,"ClinicalTrials.gov processed this data on March 31, 2020",2020-02-17,NA,NA,2020-02-17,2020-02-17,2020-02-19,Actual,NA,NA,NA,NA,NA,NA,2020-02-17,2020-02-19,Actual,"February 14, 2020",Actual,2020-02-14,February 2020,2020-02-29,"May 31, 2020",Anticipated,2020-05-31,"April 30, 2020",Anticipated,2020-04-30,NA,Observational,CMHS,,The COVID-19 Mobile Health Study (CMHS),"The COVID-19 Mobile Health Study, a Large-scale Clinical Observational Study Using nCapp",Recruiting,NA,NA,450,Anticipated,Chinese Alliance Against Lung Cancer,,NA,2,NA,FALSE,NA,NA,NA,NA,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,The anonymous clinical data for training and validation the model,2020-04-01T09:24:10Z,2020-04-01T09:24:10Z,Other,"nCapp, a cell phone-based auto-diagnosis system","Combined with 15 questions online, and a predicated formula to auto-diagnosis of the risk of COVID-19",1,Recruiting,Renmin Hospital of Wuhan University,Wuhan,Hubei,,China,1
NCT04279899,"ClinicalTrials.gov processed this data on March 31, 2020",2020-02-18,NA,NA,2020-02-19,2020-02-19,2020-02-21,Actual,NA,NA,NA,NA,NA,NA,2020-02-19,2020-02-21,Actual,"February 1, 2020",Actual,2020-02-01,February 2020,2020-02-29,"December 31, 2020",Anticipated,2020-12-31,"November 30, 2020",Anticipated,2020-11-30,NA,Observational,NA,,The Investigation of the Neonates With or With Risk of COVID-19,A Multicenter Observational Study of the Perinatal-neonatal Population With or With Risk of COVID-19 in China,Recruiting,NA,NA,100,Anticipated,Children's Hospital of Fudan University,,NA,NA,NA,FALSE,NA,NA,NA,NA,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-04-01T09:23:39Z,2020-04-01T09:23:39Z,NA,NA,NA,NA,Recruiting|Not yet recruiting,Maternal and Child Health Hospital of Hubei Province|Children Hospital of Fudan University,Wuhan|Shanghai,Hubei|Shanghai,430070|201102,China|China,2
NCT04279795,"ClinicalTrials.gov processed this data on March 31, 2020",2020-02-19,NA,NA,2020-02-19,2020-02-19,2020-02-21,Actual,NA,NA,NA,NA,NA,NA,2020-02-19,2020-02-21,Actual,"January 20, 2020",Actual,2020-01-20,February 2020,2020-02-29,"February 28, 2021",Anticipated,2021-02-28,"January 31, 2021",Anticipated,2021-01-31,NA,Observational,NA,,Detection of 2019 Novel Coronavirus in Multiple Organ System and Its Relationship With Clinical Manifestations,Study on Detection of 2019 Novel Coronavirus in Multiple Organ System and Its Relationship With Clinical Manifestations in Patients,Recruiting,NA,NA,20,Anticipated,"Third Affiliated Hospital, Sun Yat-Sen University",,NA,NA,NA,FALSE,NA,NA,NA,NA,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-04-01T09:23:39Z,2020-04-01T09:23:39Z,NA,NA,NA,NA,Recruiting,The Third Affiliated Hospital of Sun Yat-sen University,Guangzhou,Guangdong,510630,China,1
NCT04280913,"ClinicalTrials.gov processed this data on March 31, 2020",2020-02-20,NA,NA,2020-03-17,2020-02-20,2020-02-21,Actual,NA,NA,NA,NA,NA,NA,2020-03-17,2020-03-19,Actual,"February 22, 2020",Actual,2020-02-22,March 2020,2020-03-31,"March 31, 2020",Anticipated,2020-03-31,"March 31, 2020",Anticipated,2020-03-31,NA,Observational,NA,,Clinical Outcomes of Patients With COVID19,Clinical Outcomes of Hospitalized Patients With Coronavirus Disease 2019,Withdrawn,NA,NA,0,Actual,Guangzhou Institute of Respiratory Disease,,NA,1,The research project was changed.,FALSE,NA,NA,NA,NA,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-04-01T09:23:31Z,2020-04-01T09:23:31Z,Other,retrospective analysis,The investigators retrospectively analyzed the hospitalized patients with COVID-19.,1,,HuiZhou Municipal Central Hospital,Huizhou,Guangdong,516001,China,1
NCT04284046,"ClinicalTrials.gov processed this data on March 31, 2020",2020-02-22,NA,NA,2020-02-22,2020-02-22,2020-02-25,Actual,NA,NA,NA,NA,NA,NA,2020-02-22,2020-02-25,Actual,"January 31, 2020",Actual,2020-01-31,February 2020,2020-02-29,"February 18, 2020",Actual,2020-02-18,"February 18, 2020",Actual,2020-02-18,NA,Observational,NA,,CT Scores Predict Mortality in 2019-nCoV Pneumonia,CT Scores Predict Mortality in 2019-nCoV Pneumonia,Completed,NA,NA,39,Actual,"Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine",,NA,2,NA,FALSE,NA,NA,NA,NA,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-04-01T09:23:09Z,2020-04-01T09:23:09Z,Other,CT score,CT score = normal lung tissue (%) Ã—1 + GGO (%) Ã—2 + consolidation (%) Ã—3,1,,Wuhan third hospital,Wuhan,Hubei,,China,1
NCT04292327,"ClinicalTrials.gov processed this data on March 31, 2020",2020-02-23,NA,NA,2020-02-29,2020-02-29,2020-03-03,Actual,NA,NA,NA,NA,NA,NA,2020-02-29,2020-03-03,Actual,"January 1, 2020",Actual,2020-01-01,February 2020,2020-02-29,"July 31, 2020",Anticipated,2020-07-31,"April 30, 2020",Anticipated,2020-04-30,NA,Observational,2019-nCoV,,Clinical Progressive Characteristics and Treatment Effects of 2019-novel Coronavirus,Clinical Progressive Characteristics and Treatment Effects of 2019-novel Coronavirus(2019-nCoV),"Active, not recruiting",NA,NA,400,Anticipated,Fujian Provincial Hospital,,NA,3,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,NA,2020-04-01T09:22:05Z,2020-04-01T09:22:05Z,NA,NA,NA,NA,,Fujian Provincial Hospital,Fuzhou,Fujian,350000,China,1
NCT04285801,"ClinicalTrials.gov processed this data on March 31, 2020",2020-02-24,NA,NA,2020-03-08,2020-02-24,2020-02-26,Actual,NA,NA,NA,NA,NA,NA,2020-03-08,2020-03-10,Actual,"February 14, 2020",Actual,2020-02-14,March 2020,2020-03-31,"February 25, 2020",Actual,2020-02-25,"February 25, 2020",Actual,2020-02-25,NA,Observational,NA,,Critically Ill Patients With COVID-19 in Hong Kong: a Multicentre Observational Cohort Study,Critically Ill Patients With COVID-19 in Hong Kong: a Multicentre Observational Cohort Study,Completed,NA,NA,8,Actual,Chinese University of Hong Kong,,NA,1,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-04-01T09:22:55Z,2020-04-01T09:22:55Z,NA,NA,NA,NA,||,Pamela Youde Nethersole Eastern Hospital|Prince of Wales Hospital|Princess Margaret Hospital,Hong Kong|Hong Kong|Hong Kong,||,||,Hong Kong|Hong Kong|Hong Kong,3
NCT04292340,"ClinicalTrials.gov processed this data on March 31, 2020",2020-02-25,NA,NA,2020-02-28,2020-02-28,2020-03-03,Actual,NA,NA,NA,NA,NA,NA,2020-02-28,2020-03-03,Actual,"February 1, 2020",Actual,2020-02-01,February 2020,2020-02-29,"December 31, 2020",Anticipated,2020-12-31,"July 31, 2020",Anticipated,2020-07-31,NA,Observational,NA,,Anti-SARS-CoV-2 Inactivated Convalescent Plasma in the Treatment of COVID-19,The Efficacy and Safety of Anti-SARS-CoV-2 Inactivated Convalescent Plasma in the Treatment of Novel Coronavirus Pneumonia Patient (COVID-19) : An Observational Study,Recruiting,NA,NA,15,Anticipated,Shanghai Public Health Clinical Center,,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-04-01T09:22:05Z,2020-04-01T09:22:05Z,NA,NA,NA,NA,Recruiting,Shanghai Public Health Clinical Center,Shanghai,Shanghai,201508,China,1
NCT04298814,"ClinicalTrials.gov processed this data on March 31, 2020",2020-02-26,NA,NA,2020-03-04,2020-03-04,2020-03-06,Actual,NA,NA,NA,NA,NA,NA,2020-03-04,2020-03-06,Actual,"March 7, 2020",Anticipated,2020-03-07,March 2020,2020-03-31,"July 30, 2020",Anticipated,2020-07-30,"May 30, 2020",Anticipated,2020-05-30,NA,Observational,NA,,Safety Related Factors of Endotracheal Intubation in Patients With Severe Covid-19 Pneumonia,Analysis of Safety Related Factors of Endotracheal Intubation in Patients With Severe Covid-19 Pneumonia,Not yet recruiting,NA,NA,120,Anticipated,Tongji Hospital,,NA,NA,NA,FALSE,NA,NA,NA,NA,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-04-01T09:21:16Z,2020-04-01T09:21:16Z,Other,severe covid-19 pneumonia with ET,severe covid-19 pneumonia undergoing endotracheal intubation,1,NA,NA,NA,NA,NA,NA,NA
NCT04290780,"ClinicalTrials.gov processed this data on March 31, 2020",2020-02-27,NA,NA,2020-03-11,2020-02-27,2020-03-02,Actual,NA,NA,NA,NA,NA,NA,2020-03-11,2020-03-13,Actual,"March 9, 2020",Actual,2020-03-09,March 2020,2020-03-31,"October 30, 2020",Anticipated,2020-10-30,"October 10, 2020",Anticipated,2020-10-10,NA,Observational,NOSO-COR,,Multicenter Study on Nosocomial Transmission of SARS-CoV-2 Virus,Multicenter Study on Nosocomial Transmission of SARS-CoV-2 Virus,Recruiting,NA,NA,300,Anticipated,Hospices Civils de Lyon,,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,Samples With DNA,"
      nasopharyngeal swab
    ",NA,NA,NA,NA,NA,2020-04-01T09:22:16Z,2020-04-01T09:22:16Z,Other,nosocomial infection/hospital acquired infection,"When there is suspicion of a community-acquired case (admission of an infected patient) or nosocomial case (infection of a patient already hospitalized), a case report form including demographic data, medical history, and clinical and biological data on the infectious episode will be completed for each case, either patient, caregivers or health care professionals, presenting clinical signs or symptoms compatible with SARS-CoV-2 infection. The suspected cases will undergo nasopharyngeal swab collection and detection of SARS-CoV-2 in nasopharyngeal swabs will be done by real-time RT-PCR assay.
Hygiene measures applied by the service will be collected using a questionnaire as well as recommendations of the learned societies within the country regarding the risk of infection by coronavirus. In addition, data characterizing the service and hospital will also be collected (specialty, number of beds, number of nurses, doctors, etc.).",1,Recruiting|Recruiting,"Service HygiÃ¨ne, EpidÃ©miologie et PrÃ©vention|Service HygiÃ¨ne, EpidÃ©miologie et PrÃ©vention",Lyon|Lyon,|,69003|69004,France|France,2
NCT04306497,"ClinicalTrials.gov processed this data on March 31, 2020",2020-03-01,NA,NA,2020-03-14,2020-03-10,2020-03-13,Actual,NA,NA,NA,NA,NA,NA,2020-03-14,2020-03-17,Actual,"March 2, 2020",Actual,2020-03-02,January 2020,2020-01-31,May 2020,Anticipated,2020-05-31,May 2020,Anticipated,2020-05-31,NA,Observational,CTOROTSADTOC,,Clinical Trial on Regularity of TCM Syndrome and Differentiation Treatment of COVID-19.,Clinical Trial on Regularity of TCM Syndrome and Differentiation Treatment of COVID-19 in Jiangsu Province,Recruiting,NA,NA,340,Anticipated,"Jiangsu Famous Medical Technology Co., Ltd.",,NA,2,NA,FALSE,NA,NA,NA,NA,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,All researchers in this study,2020-04-01T09:20:19Z,2020-04-01T09:20:19Z,Drug,TCM prescriptions,"TCM prescriptions1:Take decocted or granule, one dose a day; TCM prescriptions2:Take decocted or granule, one dose a day.",1,Recruiting,Huai'an fourth people's Hospital,Huaian,Jiangsu,210029,China,1
NCT04292964,"ClinicalTrials.gov processed this data on March 31, 2020",2020-03-01,NA,NA,2020-03-13,2020-03-01,2020-03-03,Actual,NA,NA,NA,NA,NA,NA,2020-03-13,2020-03-17,Actual,"March 1, 2020",Actual,2020-03-01,March 2020,2020-03-31,"March 13, 2020",Actual,2020-03-13,"March 13, 2020",Actual,2020-03-13,NA,Observational,NA,,Prognostic Factors of Patients With COVID-19,Prognostic Factors of Patients With COVID-19,Completed,NA,NA,201,Actual,Chongqing Medical University,,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-04-01T09:22:01Z,2020-04-01T09:22:01Z,NA,NA,NA,NA,,The First Affiliated Hospital of Chongqing Medical University,Chongqing,,,China,1
NCT04312464,"ClinicalTrials.gov processed this data on March 31, 2020",2020-03-04,NA,NA,2020-03-13,2020-03-13,2020-03-18,Actual,NA,NA,NA,NA,NA,NA,2020-03-13,2020-03-18,Actual,"January 1, 2020",Actual,2020-01-01,March 2020,2020-03-31,"March 18, 2020",Anticipated,2020-03-18,"March 15, 2020",Anticipated,2020-03-15,NA,Observational,NA,,Myocardial Damage in COVID-19,Retrospective Study of Myocardial Damage in COVID-19,Enrolling by invitation,NA,NA,500,Anticipated,"Wuhan Union Hospital, China",,NA,2,NA,FALSE,NA,NA,NA,NA,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-04-01T09:19:32Z,2020-04-01T09:19:32Z,Other,non,no intervention,1,,"Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Wuhan,Hubei,430022,China,1
NCT04299711,"ClinicalTrials.gov processed this data on March 31, 2020",2020-03-04,NA,NA,2020-03-04,2020-03-04,2020-03-09,Actual,NA,NA,NA,NA,NA,NA,2020-03-04,2020-03-09,Actual,"October 15, 2020",Anticipated,2020-10-15,March 2020,2020-03-31,"March 15, 2022",Anticipated,2022-03-15,"November 15, 2020",Anticipated,2020-11-15,NA,Observational,NA,,Mental Health and Its Correlates Among Chinese Adolescents Exposed to the Novel Coronavirus Disease 2019,Mental Health and Its Correlates Among Chinese Adolescents Exposed to the Novel Coronavirus Disease 2019: A Longitudinal Study Protocol,Not yet recruiting,NA,NA,3428,Anticipated,University of Macau,,NA,4,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,NA,2020-04-01T09:21:10Z,2020-04-01T09:21:10Z,Other,Exposed to the novel coronavirus disease 2019,Exposed to the novel coronavirus disease 2019,1,NA,NA,NA,NA,NA,NA,NA
NCT04302688,"ClinicalTrials.gov processed this data on March 31, 2020",2020-03-07,NA,NA,2020-03-07,2020-03-07,2020-03-10,Actual,NA,NA,NA,NA,NA,NA,2020-03-07,2020-03-10,Actual,"December 10, 2019",Actual,2019-12-10,March 2020,2020-03-31,"March 4, 2020",Actual,2020-03-04,"February 10, 2020",Actual,2020-02-10,NA,Observational,NA,,Accurate Classification System for Patients With COVID-19 Pneumonitis,Accurate Classification System for Patients With COVID-19 Based on Prognostic Nomogram,Completed,NA,NA,669,Actual,Renmin Hospital of Wuhan University,,NA,2,NA,FALSE,NA,NA,NA,NA,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,Not going to share for the time being.,2020-04-01T09:20:49Z,2020-04-01T09:20:49Z,NA,NA,NA,NA,,Renmin Hospital of Wuhan University,Wuhan,Hubei,430060,China,1
NCT04306705,"ClinicalTrials.gov processed this data on March 31, 2020",2020-03-08,NA,NA,2020-03-16,2020-03-12,2020-03-13,Actual,NA,NA,NA,NA,NA,NA,2020-03-16,2020-03-17,Actual,"February 20, 2020",Actual,2020-02-20,March 2020,2020-03-31,"June 20, 2020",Anticipated,2020-06-20,"May 30, 2020",Anticipated,2020-05-30,NA,Observational,TACOS,,Tocilizumab vs CRRT in Management of Cytokine Release Syndrome (CRS) in COVID-19,A Retrospective Study of Evaluating Safety and Efficacy of Tocilizumab Compared to Continuous Renal Replacement Therapy in Controlling CRS Triggered by COVID-19,Recruiting,NA,NA,120,Anticipated,Tongji Hospital,,NA,3,NA,FALSE,NA,NA,NA,TRUE,TRUE,NA,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-04-01T09:20:18Z,2020-04-01T09:20:18Z,Drug|Other|Procedure,Tocilizumab|Standard of care|Continuous renal replacement therapy,"Administered as an intravenous infusion.|Standard of care therapy per local written policies or guidelines and includes balancing of electrolytes and acid-base, the provision of enteral or parenteral nutrients support, antibiotics therapy, oxygen therapy and noninvasive ventilation.|Catheter insertion site is femoral vein.",3,Recruiting,Tongji Hospital,Wuhan,Hubei,430030,China,1
NCT04307459,"ClinicalTrials.gov processed this data on March 31, 2020",2020-03-10,NA,NA,2020-03-14,2020-03-10,2020-03-13,Actual,NA,NA,NA,NA,NA,NA,2020-03-14,2020-03-17,Actual,"March 19, 2020",Anticipated,2020-03-19,March 2020,2020-03-31,"December 31, 2020",Anticipated,2020-12-31,"April 19, 2020",Anticipated,2020-04-19,NA,Observational,NA,,Acute Respiratory Failure and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Real Life,Acute Respiratory Failure and Continuous Positive Airway Pressure Therapy in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: a Real Life Evaluation,Not yet recruiting,NA,NA,50,Anticipated,University of Milan,,NA,1,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-04-01T09:20:12Z,2020-04-01T09:20:12Z,Other,standard operating procedures,"standard operating procedures represented by continuous positive airway pressure (CPAP) therapy or non invasive ventilation, pharmacological treatment as antiviral and antibiotic drugs, bronchodilators, xanthines, enteral nutrition, hydration.",1,,Luigi Sacco University Hospital,Milan,Lombardia,20157,Italy,1
NCT04316884,"ClinicalTrials.gov processed this data on March 31, 2020",2020-03-13,NA,NA,2020-03-18,2020-03-18,2020-03-20,Actual,NA,NA,NA,NA,NA,NA,2020-03-18,2020-03-20,Actual,"March 12, 2020",Actual,2020-03-12,March 2020,2020-03-31,"December 31, 2021",Anticipated,2021-12-31,"December 31, 2020",Anticipated,2020-12-31,NA,Observational,UMODCOVID19,,Mechanisms for Organ Dysfunction in Covid-19,Uppsala Intensive Care Study of Mechanisms for Organ Dysfunction in Covid-19,Recruiting,NA,NA,100,Anticipated,Uppsala University,,NA,1,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,Samples With DNA,"
      Plasma, Urine and Sputum
    ",NA,NA,NA,Undecided,IPD may be made available upon reasonable request.,2020-04-01T09:19:00Z,2020-04-01T09:19:00Z,NA,NA,NA,NA,Recruiting,Uppsala University Hospital,Uppsala,,75185,Sweden,1
NCT04312100,"ClinicalTrials.gov processed this data on March 31, 2020",2020-03-13,NA,NA,2020-03-14,2020-03-14,2020-03-18,Actual,NA,NA,NA,NA,NA,NA,2020-03-14,2020-03-18,Actual,"February 1, 2020",Actual,2020-02-01,March 2020,2020-03-31,February 2021,Anticipated,2021-02-28,October 2020,Anticipated,2020-10-31,NA,Observational,SOTSPC,,Sequential Oxygen Therapy Strategy for Patients With COVID-19,Sequential Oxygen Therapy Strategy for Patients With COVID-19,Recruiting,NA,NA,30,Anticipated,Henan Provincial People's Hospital,,NA,3,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,FALSE,NA,,NA,NA,NA,No,NA,2020-04-01T09:19:34Z,2020-04-01T09:19:34Z,Other,oxygen treatment,different kinds of oxygen treatments will be given to patients according to their state of illness,1,Recruiting,Henan Provincial People's Hospital,Zhengzhou,Henan,450000,China,1
NCT04311398,"ClinicalTrials.gov processed this data on March 31, 2020",2020-03-14,NA,NA,2020-03-14,2020-03-14,2020-03-17,Actual,NA,NA,NA,NA,NA,NA,2020-03-14,2020-03-17,Actual,"March 14, 2020",Anticipated,2020-03-14,March 2020,2020-03-31,"December 1, 2020",Anticipated,2020-12-01,"June 1, 2020",Anticipated,2020-06-01,NA,Observational,NA,,Development and Verification of a New Coronavirus Multiplex Nucleic Acid Detection System,Development and Verification of a New Coronavirus Multiplex Nucleic Acid Detection System,Not yet recruiting,NA,NA,100,Anticipated,Huashan Hospital,,NA,1,NA,FALSE,NA,NA,NA,NA,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-04-01T09:19:39Z,2020-04-01T09:19:39Z,Diagnostic Test,New QIAstat-Dx fully automatic multiple PCR detection platform,We use the New QIAstat-Dx fully automatic multiple PCR detection platform to test the enrolled patients,1,,Huashan Hospital of Fudan University,Shanghai,Shanghai,200040,China,1
NCT04319315,"ClinicalTrials.gov processed this data on April 02, 2020",2020-03-16,NA,NA,2020-03-20,2020-03-20,2020-03-24,Actual,NA,NA,NA,NA,NA,NA,2020-03-20,2020-03-24,Actual,"March 11, 2020",Actual,2020-03-11,March 2020,2020-03-31,"March 16, 2020",Anticipated,2020-03-16,"March 16, 2020",Actual,2020-03-16,NA,Observational,NA,,Social Media Effect on Knowledge Dissemination During COVID-19 Virus Outbreak,Impact of Social Media on Knowledge Dissemination Between Physicians During COVID-19 Virus Outbreak,Recruiting,NA,NA,400,Anticipated,Assiut University,,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-04-03T09:19:51Z,2020-04-03T09:19:51Z,Other,survey,online survey,1,Recruiting,Assiut University Hospitals,Assiut,,71515,Egypt,1
NCT04314817,"ClinicalTrials.gov processed this data on March 31, 2020",2020-03-17,NA,NA,2020-03-18,2020-03-17,2020-03-19,Actual,NA,NA,NA,NA,NA,NA,2020-03-18,2020-03-20,Actual,"March 17, 2020",Actual,2020-03-17,March 2020,2020-03-31,"January 1, 2023",Anticipated,2023-01-01,"January 1, 2021",Anticipated,2021-01-01,NA,Observational,CovidTox,,Adverse Events Related to Treatments Used Against Coronavirus Disease 2019,Adverse Events Related to Treatments Used Against Coronavirus Disease 2019,Recruiting,NA,NA,1000,Anticipated,Groupe Hospitalier Pitie-Salpetriere,,NA,1,NA,FALSE,NA,NA,NA,FALSE,TRUE,FALSE,NA,NA,FALSE,NA,,NA,NA,NA,No,No individual data is available per se. They need to be retrieved from the World Health Organization.,2020-04-01T09:19:14Z,2020-04-01T09:19:14Z,Drug,Any drug used to treat Covid-19,"lopinavir/ritonavir, remdesivir, interferon beta-1a, chloroquine and/or azithromycin. This list may be amended at a further date.",1,Recruiting,AP-HP Assistance Publique Hopitaux de Paris,Paris,,,France,1
NCT04314232,"ClinicalTrials.gov processed this data on March 31, 2020",2020-03-17,NA,NA,2020-03-17,2020-03-17,2020-03-19,Actual,NA,NA,NA,NA,NA,NA,2020-03-17,2020-03-19,Actual,"March 23, 2020",Anticipated,2020-03-23,March 2020,2020-03-31,"December 31, 2021",Anticipated,2021-12-31,"December 31, 2021",Anticipated,2021-12-31,NA,Observational,COVID MECH,,Mechanisms to Morbidity and Mortality for Covid-19,"Changes in Organ Specific Biomarkers, Virus Expression and Prognosis for Covid-19",Not yet recruiting,NA,NA,200,Anticipated,"University Hospital, Akershus",,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-04-01T09:19:19Z,2020-04-01T09:19:19Z,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
NCT04316299,"ClinicalTrials.gov processed this data on April 02, 2020",2020-03-17,NA,NA,2020-03-26,2020-03-19,2020-03-20,Actual,NA,NA,NA,NA,NA,NA,2020-03-26,2020-03-30,Actual,"February 26, 2020",Actual,2020-02-26,March 2020,2020-03-31,"March 8, 2020",Actual,2020-03-08,"February 28, 2020",Actual,2020-02-28,NA,Observational,NA,,Acute Kidney Injury in Patients Hospitalized With COVID-19,"Acute Kidney Injury in Patients Hospitalized With COVID-19 in Wuhan, China: a Single-center Retrospective Observational Study",Completed,NA,NA,287,Actual,Nanfang Hospital of Southern Medical University,,NA,2,NA,FALSE,NA,NA,NA,NA,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,NA,2020-04-03T09:20:42Z,2020-04-03T09:20:42Z,NA,NA,NA,NA,,Hankou Hospital,Wuhan,Hubei,430000,China,1
NCT04313946,"ClinicalTrials.gov processed this data on April 02, 2020",2020-03-17,NA,NA,2020-04-01,2020-03-17,2020-03-18,Actual,NA,NA,NA,NA,NA,NA,2020-04-01,2020-04-02,Estimate,"March 18, 2020",Actual,2020-03-18,April 2020,2020-04-30,"August 18, 2020",Anticipated,2020-08-18,"August 16, 2020",Anticipated,2020-08-16,NA,Observational,AI-COVID-Xr,,Artificial Intelligence Algorithms for Discriminating Between COVID-19 and Influenza Pneumonitis Using Chest X-Rays,The Benefits of Artificial Intelligence Algorithms (CNNs) for Discriminating Between COVID-19 and Influenza Pneumonitis in an Emergency Department Using Chest X-Ray Examinations,Recruiting,NA,NA,200,Anticipated,Grigore T. Popa University of Medicine and Pharmacy,,NA,1,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Yes,"Yes, we would be happy to share the algorithm code and the results with any scientist interested (without any financial interests)",2020-04-03T09:20:53Z,2020-04-03T09:20:53Z,Diagnostic Test,Scanning Chest X-rays and performing AI algorithms on images,Chest X-Rays; AI CNNs; Results,1,Recruiting|Recruiting|Recruiting,"U.O. Multidisciplinare di Patologia Mammaria e Ricerca Traslazionale; Dipartimento Universitario Clinico di Scienze Mediche, Chirurgiche e della Salute UniversitÃ  degli Studi di Trieste|University of Medicine and Pharmacy Gr T Popa|Department of Cardiology at Chelsea and Westminster NHS hospital",Cremona|IaÅŸi|London,||,26100|700503|,Italy|Romania|United Kingdom,3
NCT04321265,"ClinicalTrials.gov processed this data on April 02, 2020",2020-03-19,NA,NA,2020-03-25,2020-03-23,2020-03-25,Actual,NA,NA,NA,NA,NA,NA,2020-03-25,2020-03-27,Actual,"March 19, 2020",Actual,2020-03-19,March 2020,2020-03-31,December 2020,Anticipated,2020-12-31,September 2020,Anticipated,2020-09-30,NA,Observational,COVIP,,Outcomes and Prognostic Factors in COVID-19,Outcomes and Prognostic Factors in Coronavirus Disease (COVID-19) in Very Old Intensive Care Patients,Recruiting,NA,NA,4000,Anticipated,"Heinrich-Heine University, Duesseldorf",,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-04-03T09:18:40Z,2020-04-03T09:18:40Z,NA,NA,NA,NA,Recruiting,"Division of Cardiology, Pulmonary Disease and Vascular Medicine",Duesseldorf,,40225,Germany,1
NCT04318418,"ClinicalTrials.gov processed this data on April 02, 2020",2020-03-19,NA,NA,2020-03-19,2020-03-19,2020-03-24,Actual,NA,NA,NA,NA,NA,NA,2020-03-19,2020-03-24,Actual,"March 23, 2020",Anticipated,2020-03-23,March 2020,2020-03-31,"April 30, 2020",Anticipated,2020-04-30,"April 10, 2020",Anticipated,2020-04-10,NA,Observational,CODIV-ACE,,"ACE Inhibitors, Angiotensin II Type-I Receptor Blockers and Severity of COVID-19","ACE Inhibitors, Angiotensin II Type-I Receptor Blockers and Severity of COVID-19",Not yet recruiting,NA,NA,5000,Anticipated,Neuromed IRCCS,,NA,2,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-04-03T09:20:25Z,2020-04-03T09:20:25Z,NA,NA,NA,NA,,"IRCCS Neuromed, Department of Epidemiology and Prevention",Pozzilli,,86077,Italy,1
NCT04318366,"ClinicalTrials.gov processed this data on April 02, 2020",2020-03-19,NA,NA,2020-03-30,2020-03-23,2020-03-24,Actual,NA,NA,NA,NA,NA,NA,2020-03-30,2020-03-31,Actual,"March 19, 2020",Actual,2020-03-19,March 2020,2020-03-31,"March 19, 2022",Anticipated,2022-03-19,"March 19, 2022",Anticipated,2022-03-19,NA,Observational,COVID-BioB,,"COVID-19 Patients Characterization, Biobank, Treatment Response and Outcome Predictor","Study to Characterize Patients With SARS-Cov-2 Infection and to Create a Biobank to Identify Predictors of Disease Severity, Mortality and Treatment Response",Recruiting,NA,NA,1000,Anticipated,UniversitÃ  Vita-Salute San Raffaele,,NA,1,NA,FALSE,NA,NA,NA,NA,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-04-03T09:20:27Z,2020-04-03T09:20:27Z,Other,Observational Study,Not required,1,Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting,"Autoimmunity and Vascular Inflammation Unit, Division of Regenerative Medicine, Stem Cells and Gene Therapy - IRCCS San Raffaele Scientific Institute|AIDS Immunopathogenesis Unit - IRCCS San Raffaele Scientific Institute|Department of Infection Diseases - IRCCS San Raffaele Scientific Institute -|Department of Internal Medicine - IRCCS San Raffaele Scientific Institute|Diabetes Research Institute -IRCCS San Raffaele Scientific Istitute|Division of Immunology, Transplantation and Infectious Diseases - IRCCS San Raffaele Scientific Institute|Division of Research of Regenerative Medicine, Cell and Gene Therapy - IRCCS San Raffaele Scientific Istitute|Laboratory of Microbiology and Virology - IRCCS San Raffaele Scientific Institute|Nephrology Unit - IRCCS San Raffaele Scientific Institute|Strategic Program in Nephrology and Dialysis - IRCCS San Raffaele Scientific Institute|Viral pathogens and biosafety Unit - IRCCS San Raffaele Scietific Institute|Unit of Immunology, Rheumatology, Allergy and Rare Diseases - IRCCS San Raffaele Scientific Institute|UniversitÃ  Vita-Salute San Raffaele",Milan|Milan|Milan|Milan|Milan|Milan|Milan|Milan|Milan|Milan|Milan|Milan|Milano,Lombardy|Lombardy|Lombardy|Lombardy|Lombardy|Lombardy|Lombardy|Lombardy|Lombardy|Lombardy|Lombardy|Lombardy|Mi,2012|20132|20132|20132|20132|20132|20132|20132|20132|20132|20132|2132|20132,Italy|Italy|Italy|Italy|Italy|Italy|Italy|Italy|Italy|Italy|Italy|Italy|Italy,13
NCT04317365,"ClinicalTrials.gov processed this data on April 02, 2020",2020-03-19,NA,NA,2020-03-31,2020-03-19,2020-03-23,Actual,NA,NA,NA,NA,NA,NA,2020-03-31,2020-04-01,Actual,"March 24, 2020",Anticipated,2020-03-24,March 2020,2020-03-31,"May 2, 2020",Anticipated,2020-05-02,"April 27, 2020",Anticipated,2020-04-27,NA,Observational,NA,,Awareness Between Pregnant Women Regarding Corona,Awareness Between Pregnant Women Regarding Corona Virus,Not yet recruiting,NA,NA,200,Anticipated,Aljazeera Hospital,,NA,NA,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-04-03T09:20:34Z,2020-04-03T09:20:34Z,NA,NA,NA,NA,,Algazeerah and Kasralainy hospital,Giza,,,Egypt,1
NCT04316949,"ClinicalTrials.gov processed this data on April 02, 2020",2020-03-19,NA,NA,2020-03-25,2020-03-19,2020-03-20,Actual,NA,NA,NA,NA,NA,NA,2020-03-25,2020-03-27,Actual,"March 20, 2020",Actual,2020-03-20,March 2020,2020-03-31,"May 31, 2020",Anticipated,2020-05-31,"April 30, 2020",Anticipated,2020-04-30,NA,Observational,NA,,Predictors of Respiratory Failure in SARS-Cov-2 Infection,Predictors of Respiratory Failure Requiring ICU Admission Among Hospitalized Patients With SARS-Cov-2 Infection,Recruiting,NA,NA,350,Anticipated,University of Bologna,,NA,2,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,Participant from other centers may request to analyze the registry for other purposes upon IRB and study group approval,2020-04-03T09:20:36Z,2020-04-03T09:20:36Z,NA,NA,NA,NA,Recruiting,University of Bologna - Department of Medical and Surgical Sciences,Bologna,,40138,Italy,1
NCT04320017,"ClinicalTrials.gov processed this data on April 02, 2020",2020-03-20,NA,NA,2020-03-23,2020-03-23,2020-03-24,Actual,NA,NA,NA,NA,NA,NA,2020-03-23,2020-03-24,Actual,"March 20, 2020",Actual,2020-03-20,March 2020,2020-03-31,"May 20, 2020",Anticipated,2020-05-20,"May 20, 2020",Anticipated,2020-05-20,NA,Observational,JOCOVID,,Joint Use of Electrocardiogram and Transthoracic Echocardiography in an Observational Study to Monitor Cardio-vascular Events in Patients Diagnosed With COVID-19,Joint Use of Electrocardiogram and Transthoracic Echocardiography in an Observational Study to Monitor Cardio-vascular Events in Patients Diagnosed With COVID-19,Recruiting,NA,NA,500,Anticipated,Groupe Hospitalier Pitie-Salpetriere,,NA,1,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,NA,2020-04-03T09:19:27Z,2020-04-03T09:19:27Z,Diagnostic Test,Electrocardiogram and transthoracic echocardiography,12 derivations electrocardiogram done at baseline transthoracic echocardiography,1,Recruiting,Clinical Investigation Center PitiÃ©-SalpÃªtriÃ¨re,Paris,,75013,France,1
NCT04319211,"ClinicalTrials.gov processed this data on April 02, 2020",2020-03-20,NA,NA,2020-03-23,2020-03-23,2020-03-24,Actual,NA,NA,NA,NA,NA,NA,2020-03-23,2020-03-24,Actual,"March 25, 2020",Anticipated,2020-03-25,March 2020,2020-03-31,"July 20, 2020",Anticipated,2020-07-20,"May 15, 2020",Anticipated,2020-05-15,NA,Observational,COVID-19,,"Effects of Social Isolation From Coronavirus; on Physical Activity, Quality of Life and Stress","Investigation of Physical Activity, Quality of Life and Stress Levels of Individuals Who Live in Their Homes Isolated Because of Coronavirus (COVID-19) Disease",Not yet recruiting,NA,NA,200,Anticipated,Istanbul University-Cerrahpasa,,NA,1,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-04-03T09:19:55Z,2020-04-03T09:19:55Z,Other,"Determination of physical activity, quality of life, stress levels of isolated people at home with the danger of coronavirus.","The study will include those who isolate themselves at home for fear of contracting Coronavirus disease or suspected of having it. The last three sections of the International Physical Activity Questionnaire (IPAQ) will be used to evaluate the current physical activity level of the participants. Parameters such as housework, home care and family care, rest, sports and leisure physical activities, sitting time will be evaluated. Short Form 12 (Short Form12- SF12) quality of life scale will be used to evaluate health-related quality of life. Beck Depression Scale will be applied to investigate the stress levels of the individuals participating in our study.",1,,Istanbul University Cerrahpasa,Istanbul,,,Turkey,1
NCT04319172,"ClinicalTrials.gov processed this data on April 02, 2020",2020-03-20,NA,NA,2020-03-23,2020-03-23,2020-03-24,Actual,NA,NA,NA,NA,NA,NA,2020-03-23,2020-03-24,Actual,March 2020,Anticipated,2020-03-31,March 2020,2020-03-31,April 2022,Anticipated,2022-04-30,March 2022,Anticipated,2022-03-31,NA,Observational,COVIDSOT,,Multicentric Study of Coronavirus Disease 2019 (COVID-2019) in Solid Organ Transplant Recipients,Multicentric Study of Coronavirus Disease 2019 (COVID-2019) in Solid Organ Transplant Recipients,Not yet recruiting,NA,NA,50,Anticipated,FundaciÃ³n PÃºblica Andaluza para la gestiÃ³n de la InvestigaciÃ³n en Sevilla,,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,Samples Without DNA,"
      -  Biochemical analysis

        -  Hemogram

        -  Microbiological testing will be made: blood culture, pleural liquid culture, gram stain
           and culture of sputum, detection of pneumococcus and Legionella pneumophila antigen in
           urine, in cases of pneumonia.

        -  Nasopharyngeal swabs
    ",One year after the initiation of the study,Spanish Network for Research in Infectious Disease (REIPI) and Group for the Study of Infection in Transplantation and the Immunocompromised Host (GESITRA-IC),NA,Yes,Planning for the study will be shared with potential sites pertaining to Spanish Network for Research in Infectious Disease (REIPI) and Group for the Study of Infection in Transplantation and the Immunocompromised Host (GESITRA-IC) for participation. IPD is not foreseen out of this groups due to the specific characteristics of patients and sites to be candidates for study participation.,2020-04-03T09:19:56Z,2020-04-03T09:19:56Z,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
NCT04318301,"ClinicalTrials.gov processed this data on April 02, 2020",2020-03-20,NA,NA,2020-03-21,2020-03-20,2020-03-23,Actual,NA,NA,NA,NA,NA,NA,2020-03-21,2020-03-24,Actual,"March 21, 2020",Actual,2020-03-21,March 2020,2020-03-31,"March 30, 2020",Anticipated,2020-03-30,"March 28, 2020",Anticipated,2020-03-28,NA,Observational,HT-COVID19,,Hypertension in Patients Hospitalized With COVID-19,"Hypertension in Patients Hospitalized With COVID-19 in Wuhan, China: A Single-center Retrospective Observational Study","Active, not recruiting",NA,NA,275,Actual,Nanfang Hospital of Southern Medical University,,NA,2,NA,FALSE,NA,NA,NA,NA,FALSE,FALSE,NA,NA,NA,None Retained,"
      Blood
    ",NA,NA,NA,Undecided,NA,2020-04-03T09:20:28Z,2020-04-03T09:20:28Z,NA,NA,NA,NA,,Hankou Hospital,Hankou,Hubei,430000,China,1
NCT04322513,"ClinicalTrials.gov processed this data on April 02, 2020",2020-03-23,NA,NA,2020-03-25,2020-03-23,2020-03-26,Actual,NA,NA,NA,NA,NA,NA,2020-03-25,2020-03-27,Actual,"March 24, 2020",Actual,2020-03-24,March 2020,2020-03-31,"August 30, 2020",Anticipated,2020-08-30,"June 30, 2020",Anticipated,2020-06-30,NA,Observational,B-DT-COV2,,Biomarkers for Identification of SARS-COV-2 Infection,Biomarkers Identification for Diagnosis and Treatment of SARS-COV-2 Infection,Recruiting,NA,NA,110,Anticipated,University of Catanzaro,,NA,2,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-04-03T09:17:53Z,2020-04-03T09:17:53Z,Diagnostic Test,Biomarkers expression,Evaluation in biomarkers expression between 2 groups,1,Recruiting,Luca Gallelli,Catanzaro,,88100,Italy,1
NCT04322487,"ClinicalTrials.gov processed this data on April 02, 2020",2020-03-23,NA,NA,2020-03-25,2020-03-24,2020-03-26,Actual,NA,NA,NA,NA,NA,NA,2020-03-25,2020-03-27,Actual,"April 1, 2020",Anticipated,2020-04-01,March 2020,2020-03-31,"January 15, 2021",Anticipated,2021-01-15,"December 31, 2020",Anticipated,2020-12-31,NA,Observational,LUSCOVID19,,"Simple, Safe, Same: Lung Ultrasound for COVID-19","Proposal for International Standardization of the Use of Lung Ultrasound for COVID-19 Patients; a Simple, Quantitative, Reproducible Method",Not yet recruiting,NA,NA,100,Anticipated,Catholic University of the Sacred Heart,,NA,NA,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-04-03T09:17:54Z,2020-04-03T09:17:54Z,Diagnostic Test,Lung ultrasound,"A proposal of a standardized approach in order to optimize the use of lung ultrasound in COVID-19 patients. We focus on equipment, procedure, classification and data-sharing.",1,||||||||,"Bresciamed|Pulmonary Medicine Unit, Lodi General Hospital|118 USL Nordovest Toscana|Diagnostic and Interventional Ultrasound Unit, Valle del Serchio General Hospital|Emergency Department, Fondazione IRCCS Policlinico San Matteo, and Department of Internal Medicine and Therapeutics, University of Pavia|Department of woman and child health and public health, Fondazione Policlinico Universitario A. Gemelli IRCCS|Pulmonary Medicine Unit, Dept. Medical and Surgical Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS|Department of Information Engineering and Computer Science, Ultrasound Laboratory Trento, University of Trento|Emergency Medicine Unit, General Hospital",Brescia|Lodi|Lucca|Lucca|Pavia|Roma|Roma|Trento|Voghera,||||||||,|||||00168|00168||,Italy|Italy|Italy|Italy|Italy|Italy|Italy|Italy|Italy,9
NCT04321369,"ClinicalTrials.gov processed this data on April 02, 2020",2020-03-23,NA,NA,2020-03-23,2020-03-23,2020-03-25,Actual,NA,NA,NA,NA,NA,NA,2020-03-23,2020-03-25,Actual,"March 9, 2020",Actual,2020-03-09,March 2020,2020-03-31,"March 23, 2020",Actual,2020-03-23,"March 23, 2020",Actual,2020-03-23,NA,Observational,NA,,Impact of Swab Site and Sample Collector on Testing Sensitivity for SARS-CoV-2 Virus in Symptomatic Individuals,Impact of Swab Site and Sample Collector on Testing Sensitivity for SARS-CoV-2 Virus in Symptomatic Individuals,Completed,NA,NA,533,Actual,UnitedHealth Group,,NA,NA,NA,FALSE,NA,NA,NA,NA,FALSE,FALSE,NA,NA,NA,None Retained,"
      Four nasal swabs will be collected on each participant
    ",March 2020 - June 2020,". Data will be shared between the participating clinics, UHG and collaborating partners performing the analysis of the samples and returning results as outlined in data sharing agreements.",NA,Yes,"All patients who participate in this operational pilot will have standard COVID-19 screening information entered into their electronic medical record. The collection locations and source of collection (medical personnel versus patient) will need to be clearly distinguished for the purposes of this project. Data resulting from analysis of the samples will also be stored in the electronic medical record and any positive results will be reported accordingly to public health officials as required. The data collected due to this operational effort will be extracted from the medical record and stored for additional research analysis to demonstrate equivalence between location in the nose for the collection of the sample and similarity between sample collected by medical personnel and samples collected by the patient. Data will be shared between the participating clinics, UHG and collaborating partners performing the analysis of the samples and returning results.",2020-04-03T09:18:36Z,2020-04-03T09:18:36Z,Diagnostic Test,Testing Sensitivity for SARS-CoV-2 Virus in Symptomatic Individuals,"This is an operational project. Patients will collect a sample from the tongue, nasal cavity and MT and then clinicians will collect a NP sample from the nostril corresponding to each participant's dominant hand.",1,,Everett Clinic,Seattle,Washington,98133,United States,1
NCT04320732,"ClinicalTrials.gov processed this data on April 02, 2020",2020-03-23,NA,NA,2020-03-27,2020-03-23,2020-03-25,Actual,NA,NA,NA,NA,NA,NA,2020-03-27,2020-03-31,Actual,"March 27, 2020",Actual,2020-03-27,March 2020,2020-03-31,"March 20, 2030",Anticipated,2030-03-20,"March 27, 2022",Anticipated,2022-03-27,NA,Observational,NA,,Risk Factors for Community- and Workplace Transmission of COVID-19,Risk Factors for Community- and Workplace Transmission of COVID-19,Recruiting,NA,NA,50000,Anticipated,Oslo University Hospital,,NA,5,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,Samples With DNA,"
      Blood and upper repiratory samples will be collected from some participants.
    ",NA,NA,NA,No,"European GDPR regulations severely limits IPD, but the study will share data to the largest extent possible within GDPR.",2020-04-03T09:19:02Z,2020-04-03T09:19:02Z,Behavioral,Observation of behavior and COVID-19 infection will be conducted.,"No intervention, only prospective observation of behavior will be conducted by a questionnaire.",1,Recruiting,Oslo University Hospital,Oslo,,0424,Norway,1
NCT04320511,"ClinicalTrials.gov processed this data on April 02, 2020",2020-03-23,NA,NA,2020-03-30,2020-03-23,2020-03-25,Actual,NA,NA,NA,NA,NA,NA,2020-03-30,2020-03-31,Actual,April 2020,Anticipated,2020-04-30,March 2020,2020-03-31,March 2022,Anticipated,2022-03-31,March 2021,Anticipated,2021-03-31,NA,Observational,NA,,Beaumont Quantitative Lung Function Imaging to Characterize Patients With SARS-COV 2,"COVID CT, Beaumont Quantitative Lung Function Imaging to Characterize Patients With SARS-COV 2",Not yet recruiting,NA,NA,25,Anticipated,William Beaumont Hospitals,,NA,1,NA,FALSE,NA,NA,NA,FALSE,FALSE,TRUE,NA,NA,FALSE,NA,,NA,NA,NA,No,NA,2020-04-03T09:19:09Z,2020-04-03T09:19:09Z,Device,CT-V,"CT-V is an image processing-based modality that recovers changes in local tissue volumes, induced by respiratory motion, from an inspiration-expiration CT (IE-CT) scan or a standard non-contrast 4D CT scan",1,,Beaumont Health,Royal Oak,Michigan,48073,United States,1
NCT04325919,"ClinicalTrials.gov processed this data on April 02, 2020",2020-03-24,NA,NA,2020-03-26,2020-03-26,2020-03-30,Actual,NA,NA,NA,NA,NA,NA,2020-03-26,2020-03-30,Actual,"February 24, 2020",Actual,2020-02-24,March 2020,2020-03-31,"June 17, 2021",Anticipated,2021-06-17,"February 28, 2021",Anticipated,2021-02-28,NA,Observational,NA,,Coronavirus Disease 2019 (COVID-19) Study of Hospitalized Patients in Hong Kong,"Comprehensive Clinical, Virological, Microbiological, Immunological and Laboratory Monitoring of Patients Hospitalized With Coronavirus Disease 2019 (COVID-19)",Recruiting,NA,NA,170,Anticipated,Chinese University of Hong Kong,,NA,NA,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,NA,2020-04-03T09:15:52Z,2020-04-03T09:15:52Z,Other,No intervention,No intervention,1,Recruiting,Prince of Wales Hospital,Sha Tin,,,Hong Kong,1
NCT04324866,"ClinicalTrials.gov processed this data on April 02, 2020",2020-03-24,NA,NA,2020-03-26,2020-03-26,2020-03-27,Actual,NA,NA,NA,NA,NA,NA,2020-03-26,2020-03-27,Actual,"April 1, 2020",Anticipated,2020-04-01,March 2020,2020-03-31,December 2020,Anticipated,2020-12-31,November 2020,Anticipated,2020-11-30,NA,Observational,NA,,Prevalence and Incidence of COVID-19 Infection in Patients With Chronic Plaque Psoriasis on Immunosuppressant Therapy,Prevalence and Incidence of COVID-19 Infection in Patients With Chronic Plaque Psoriasis on Immunosuppressant Therapy,Not yet recruiting,NA,NA,300,Anticipated,Universita di Verona,,NA,3,NA,FALSE,NA,NA,NA,NA,FALSE,FALSE,NA,NA,NA,Samples Without DNA,"
      Nasopharyngeal swabs
    ",NA,NA,NA,NA,NA,2020-04-03T09:16:31Z,2020-04-03T09:16:31Z,Diagnostic Test,Nasopharyngeal swab,Nasopharyngeal swab for the molecular diagnosis of COVID-19 infection,1,NA,NA,NA,NA,NA,NA,NA
NCT04323787,"ClinicalTrials.gov processed this data on April 02, 2020",2020-03-24,NA,NA,2020-03-30,2020-03-25,2020-03-27,Actual,NA,NA,NA,NA,NA,NA,2020-03-30,2020-04-01,Actual,"March 30, 2020",Actual,2020-03-30,March 2020,2020-03-31,"April 30, 2021",Anticipated,2021-04-30,"April 30, 2021",Anticipated,2021-04-30,NA,Observational,VIRUS,,Viral Infection and Respiratory Illness Universal Study[VIRUS]: COVID19 Registry,Viral Infection and Respiratory Illness Universal Study[VIRUS]: COVID-19 Registry and Validation of C2D2 (Critical Care Data Dictionary),Recruiting,NA,NA,50000,Anticipated,Mayo Clinic,,NA,1,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-04-03T09:17:08Z,2020-04-03T09:17:08Z,Other,observational,No Intervention,1,Recruiting|Recruiting|Not yet recruiting|Recruiting,Mayo Clinic in Arizona|Mayo Clinic in Florida|Society of Critical Care Medicine (150+ sites)|Rahul Kashyap,Scottsdale|Jacksonville|Chicago|Rochester,Arizona|Florida|Illinois|Minnesota,85259|32224|60056|55905,United States|United States|United States|United States,4
NCT04322279,"ClinicalTrials.gov processed this data on April 02, 2020",2020-03-24,NA,NA,2020-03-24,2020-03-24,2020-03-26,Actual,NA,NA,NA,NA,NA,NA,2020-03-24,2020-03-26,Actual,"March 9, 2020",Actual,2020-03-09,March 2020,2020-03-31,"May 1, 2020",Anticipated,2020-05-01,"May 1, 2020",Anticipated,2020-05-01,NA,Observational,NA,,Factors Associated With a Positive SARS-CoV-2 Serology in Contact Subjects at High/Moderate Risk of Coronavirus SARS-CoV-2 Infection (CoV-CONTACT-SERO),Factors Associated With a Positive SARS-CoV-2 Serology in Contact Subjects at High/Moderate Risk of Coronavirus SARS-CoV-2 Infection,Recruiting,NA,NA,300,Anticipated,"Institut National de la SantÃ© Et de la Recherche MÃ©dicale, France",,NA,NA,NA,FALSE,NA,NA,NA,NA,FALSE,FALSE,NA,NA,NA,Samples With DNA,"
      Blood samples
    ",NA,NA,NA,Undecided,NA,2020-04-03T09:18:02Z,2020-04-03T09:18:02Z,Diagnostic Test|Genetic,Serology|Sequencing,SARS-CoV-2 serology|Whole exome sequencing,2,Recruiting,CIC 1425,Paris,,,France,1
NCT04322188,"ClinicalTrials.gov processed this data on April 02, 2020",2020-03-24,NA,NA,2020-03-28,2020-03-25,2020-03-26,Actual,NA,NA,NA,NA,NA,NA,2020-03-28,2020-03-31,Actual,"March 19, 2020",Actual,2020-03-19,March 2020,2020-03-31,"May 19, 2020",Anticipated,2020-05-19,"May 19, 2020",Anticipated,2020-05-19,NA,Observational,SISCO,,An Observational Case-control Study of the Use of Siltuximab in ARDS Patients Diagnosed With COVID-19 Infection,An Observational Case-control Study of the Use of Siltuximab (SYLVANT) in Patients Diagnosed With COVID-19 Infection Who Have Developed Serious Respiratory Complications,Recruiting,NA,NA,50,Anticipated,A.O. Ospedale Papa Giovanni XXIII,,NA,2,NA,FALSE,NA,NA,NA,NA,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,NA,2020-04-03T09:18:06Z,2020-04-03T09:18:06Z,NA,NA,NA,NA,Recruiting,ASST - Papa Giovanni XXIII,Bergamo,,24127,Italy,1
NCT04327180,"ClinicalTrials.gov processed this data on April 02, 2020",2020-03-25,NA,NA,2020-04-01,2020-03-27,2020-03-30,Actual,NA,NA,NA,NA,NA,NA,2020-04-01,2020-04-02,Estimate,"March 30, 2020",Actual,2020-03-30,April 2020,2020-04-30,September 2021,Anticipated,2021-09-30,September 2021,Anticipated,2021-09-30,NA,Observational,PREDICT,,PREdiction of DIagnosed Covid-19 infecTion in IUC Patients,PCR-COVID-19 Predictors of Positivity in Patients Admitted to ICU for Respiratory Infection: A Prospective Observational Cohort Study,Recruiting,NA,NA,500,Anticipated,"University Hospital, Lille",,NA,1,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-04-03T09:15:02Z,2020-04-03T09:15:02Z,NA,NA,NA,NA,Recruiting,"HÃ´pital Roger Salengro, ICU, CHU Lille",Lille,,59037,France,1
NCT04324736,"ClinicalTrials.gov processed this data on April 02, 2020",2020-03-25,NA,NA,2020-03-27,2020-03-25,2020-03-27,Actual,NA,NA,NA,NA,NA,NA,2020-03-27,2020-03-31,Actual,"March 30, 2020",Anticipated,2020-03-30,March 2020,2020-03-31,"May 8, 2020",Anticipated,2020-05-08,"April 10, 2020",Anticipated,2020-04-10,NA,Observational,CORONADO,,"""Coronavirus SARS-CoV2 and Diabetes Outcomes""","""Coronavirus SARS-CoV2 and Diabetes Outcomes""",Not yet recruiting,NA,NA,300,Anticipated,Nantes University Hospital,,NA,1,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,NA,2020-04-03T09:16:35Z,2020-04-03T09:16:35Z,Other,no interventional study,no interventional study,1,NA,NA,NA,NA,NA,NA,NA
NCT04324684,"ClinicalTrials.gov processed this data on April 02, 2020",2020-03-25,NA,NA,2020-03-31,2020-03-25,2020-03-27,Actual,NA,NA,NA,NA,NA,NA,2020-03-31,2020-04-02,Estimate,"March 31, 2020",Actual,2020-03-31,March 2020,2020-03-31,"June 15, 2020",Anticipated,2020-06-15,"May 31, 2020",Anticipated,2020-05-31,NA,Observational,NIKE_C19,,Prognostic Factors Keeping Track for Covid19 Pneumonia,Time of Recovery and Prognostic Factors of Covid19 Pneumonia,Recruiting,NA,NA,198,Anticipated,Catholic University of the Sacred Heart,,NA,2,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,Samples Without DNA,"
      Plasma samples
    ",NA,NA,NA,NA,NA,2020-04-03T09:16:37Z,2020-04-03T09:16:37Z,NA,NA,NA,NA,Recruiting,Fondazione Policlinico Universitario A. Gemelli IRCCS,Roma,,,Italy,1
NCT04324047,"ClinicalTrials.gov processed this data on April 02, 2020",2020-03-25,NA,NA,2020-03-31,2020-03-25,2020-03-27,Actual,NA,NA,NA,NA,NA,NA,2020-03-31,2020-04-01,Actual,"March 27, 2020",Actual,2020-03-27,March 2020,2020-03-31,"December 31, 2021",Anticipated,2021-12-31,"March 27, 2021",Anticipated,2021-03-27,NA,Observational,CORIMUNO-19,,Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients,Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients,Recruiting,NA,NA,1000,Anticipated,Assistance Publique - HÃ´pitaux de Paris,,NA,NA,NA,FALSE,NA,NA,NA,NA,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Yes,NA,2020-04-03T09:16:58Z,2020-04-03T09:16:58Z,NA,NA,NA,NA,Recruiting|Recruiting|Recruiting,Kremlin Bictre APHP|Cochin Aphp|Hegp Aphp,Le Kremlin-BicÃªtre|Paris|Paris,Ile De France|Ile De France|Ile De France,||,France|France|France,3
NCT04323644,"ClinicalTrials.gov processed this data on April 02, 2020",2020-03-25,NA,NA,2020-03-25,2020-03-25,2020-03-26,Actual,NA,NA,NA,NA,NA,NA,2020-03-25,2020-03-26,Actual,"March 31, 2020",Anticipated,2020-03-31,March 2020,2020-03-31,"September 30, 2020",Anticipated,2020-09-30,"September 30, 2020",Anticipated,2020-09-30,NA,Observational,CovidSurg,,Outcomes of Surgery in COVID-19 Infection: International Cohort Study (CovidSurg),Outcomes of Surgery in COVID-19 Infection: International Cohort Study (CovidSurg),Not yet recruiting,NA,NA,1000,Anticipated,University of Birmingham,,NA,1,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,No individual participant data will be available to other researchers,2020-04-03T09:17:13Z,2020-04-03T09:17:13Z,Procedure,Surgery,Emergency or elective surgery,1,NA,NA,NA,NA,NA,NA,NA
NCT04329507,"ClinicalTrials.gov processed this data on April 02, 2020",2020-03-26,NA,NA,2020-03-30,2020-03-30,2020-04-01,Actual,NA,NA,NA,NA,NA,NA,2020-03-30,2020-04-01,Actual,"March 25, 2020",Anticipated,2020-03-25,March 2020,2020-03-31,"March 25, 2020",Anticipated,2020-03-25,"March 25, 2020",Anticipated,2020-03-25,NA,Observational,NA,,Non-invasive Detection of Pneumonia in Context of Covid-19 Using Gas Chromatography - Ion Mobility Spectrometry (GC-IMS),Non-invasive Detection of Pneumonia in Context of Covid-19 Using Gas Chromatography - Ion Mobility Spectrometry (GC-IMS),Not yet recruiting,NA,NA,200,Anticipated,NHS Lothian,,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,no plan made as yet - this research needs to be expedited during the pandemic,2020-04-03T09:13:34Z,2020-04-03T09:13:34Z,Diagnostic Test,Breath test,collection of an exhaled breath sample,1,NA,NA,NA,NA,NA,NA,NA
NCT04327804,"ClinicalTrials.gov processed this data on April 02, 2020",2020-03-26,NA,NA,2020-03-26,2020-03-26,2020-03-31,Actual,NA,NA,NA,NA,NA,NA,2020-03-26,2020-03-31,Actual,"March 25, 2020",Actual,2020-03-25,March 2020,2020-03-31,"April 10, 2020",Anticipated,2020-04-10,"April 3, 2020",Anticipated,2020-04-03,NA,Observational,NA,,A Longitudinal Study of SARS-CoV-2 Positive Patients Testing Nasal Swabs and Collecting Blood Samples for Research,A Longitudinal Study of SARS-CoV-2 Positive Patients Testing Nasal Swabs and Collecting Blood Samples for Research,Recruiting,NA,NA,120,Anticipated,UnitedHealth Group,,NA,2,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,Samples Without DNA,"
      Patients will return at the following times to complete the same battery of sample
      collection:

        -  7-9 days after initially testing positive;

        -  14-18 days after initially testing positive;

        -  28-42 days after initially testing positive. Additional visits, during which additional
           samples could be collected may occur after 42 days if agreeable to the participants and
           desired by the study investigators.
    ",2 months,"The data collected due to this study will be extracted from the medical record and stored for additional research analysis to demonstrate equivalence between location in the two nasal swabs. Blood samples will be delivered to PATH and the Mayo Clinic for storage and analysis. Patients may not have access to these samples or the blood features derived from them after sample collection. Data will be shared between the participating clinics, UHG and collaborating partners performing the analysis of the samples and returning results.",NA,Yes,"Four data sources will be recorded for each patient who consents to participate in the study:
Electronic medical record (EMR);
Results of testing from the foam and polyester nasal swab samples;
Results of any blood testing performed on the blood samples;
Responses to a set of standard questions posed to each participant.",2020-04-03T09:14:38Z,2020-04-03T09:14:38Z,Diagnostic Test,Odd/Even birth year intervention groups,The nostril used and order of testing will be different in each arm.,1,Recruiting,Everett Clinic,Seattle,Washington,98133,United States,1
NCT04326725,"ClinicalTrials.gov processed this data on April 02, 2020",2020-03-26,NA,NA,2020-03-27,2020-03-27,2020-03-30,Actual,NA,NA,NA,NA,NA,NA,2020-03-27,2020-03-30,Actual,"March 20, 2020",Actual,2020-03-20,March 2020,2020-03-31,"September 1, 2020",Anticipated,2020-09-01,"July 1, 2020",Anticipated,2020-07-01,NA,Observational,NA,,Proflaxis Using Hydroxychloroquine Plus Vitamins-Zinc During COVID-19 Pandemia,"Proflaxis for Healthcare Professionals Using Hydroxychloroquine Plus Vitamin Combining Vitamins A, C, D and Zinc During COVID-19 Pandemia: An Observational Study",Recruiting,NA,NA,80,Anticipated,Istinye University,,NA,1,NA,FALSE,NA,NA,NA,FALSE,TRUE,FALSE,NA,NA,FALSE,NA,,NA,NA,NA,NA,NA,2020-04-03T09:15:21Z,2020-04-03T09:15:21Z,Drug,Plaquenil 200Mg Tablet,health workers under risk who took this medications,1,Recruiting,Istinye University Medical School,Istanbul,,34010,Turkey,1
NCT04326387,"ClinicalTrials.gov processed this data on April 02, 2020",2020-03-26,NA,NA,2020-03-27,2020-03-27,2020-03-30,Actual,NA,NA,NA,NA,NA,NA,2020-03-27,2020-03-30,Actual,"April 8, 2020",Anticipated,2020-04-08,March 2020,2020-03-31,"October 7, 2021",Anticipated,2021-10-07,"April 7, 2021",Anticipated,2021-04-07,NA,Observational,COVIDx,,Evaluation of Novel Diagnostic Tests for 2019-nCOV,Evaluation of Novel Diagnostic Tests for 2019-nCOV,Not yet recruiting,NA,NA,200,Anticipated,Cambridge University Hospitals NHS Foundation Trust,,NA,1,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,Samples Without DNA,"
      Throat/Nasal Swab, Nasopharyngeal Swab, Endotracheal tube aspirate and whole blood-serum for
      viral-RNA analysis
    ",NA,NA,NA,Undecided,NA,2020-04-03T09:15:33Z,2020-04-03T09:15:33Z,Diagnostic Test|Diagnostic Test|Diagnostic Test|Diagnostic Test,Radiological Detection|Cambridge Validated Viral Detection Method|SAMBA II (Diagnostic for the Real World)|Public Health England Gold Standard,Chest X-ray & CT Scan detection of viral infection in the lungs|Reverse Transcription PCR|Point of care Isothermal-PCR Viral RNA Amplication for virus detection|Reverse Transcription PCR,4,NA,NA,NA,NA,NA,NA,NA
NCT04325646,"ClinicalTrials.gov processed this data on April 02, 2020",2020-03-26,NA,NA,2020-03-27,2020-03-26,2020-03-27,Actual,NA,NA,NA,NA,NA,NA,2020-03-27,2020-03-31,Actual,"March 13, 2020",Actual,2020-03-13,March 2020,2020-03-31,"February 28, 2023",Anticipated,2023-02-28,"February 28, 2021",Anticipated,2021-02-28,NA,Observational,CORSER,,Sero-epidemiological Study of the SARS-CoV-2 Virus in France: Constitution of a Collection of Human Biological Samples,Sero-epidemiological Study of the SARS-CoV-2 Virus in France: Constitution of a Collection of Human Biological Samples,Recruiting,NA,NA,1000,Anticipated,Institut Pasteur,,NA,4,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,Samples With DNA,"
      serum, plasma
    ",NA,NA,NA,Undecided,NA,2020-04-03T09:16:02Z,2020-04-03T09:16:02Z,Other,Human Biological samples,Blood samples for serological tests,1,Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting,CHU Amiens-Picardie|CHU FranÃ§ois Mitterand|CHU Limoges|HÃ´pital de la Croix Rousse|HÃ´pitaux de Brabois|CHR OrlÃ©ans|Institut Pasteur|CHU Poitiers|HÃ´pital Pontchaillou|CHU Saint-Etienne|CH de Tourcoing|HÃ´pital Bretonneau,Amiens|Dijon|Limoges|Lyon|Nancy|OrlÃ©ans|Paris|Poitiers|Rennes|Saint-Ã‰tienne|Tourcoing|Tours,|||||||||||,||||||75015|||||,France|France|France|France|France|France|France|France|France|France|France|France,12
NCT04331106,"ClinicalTrials.gov processed this data on April 02, 2020",2020-03-27,NA,NA,2020-03-30,2020-03-30,2020-04-02,Estimate,NA,NA,NA,NA,NA,NA,2020-03-30,2020-04-02,Estimate,"March 27, 2020",Actual,2020-03-27,March 2020,2020-03-31,September 2021,Anticipated,2021-09-30,September 2020,Anticipated,2020-09-30,NA,Observational,CORA,,Survey of the Anxiety Associated With the SARS-CoV-2 Pandemic,Online-based Survey of the Anxiety Associated With the SARS-CoV-2 Pandemic in the General Population in Germany,Recruiting,NA,NA,1000,Anticipated,"Charite University, Berlin, Germany",,NA,1,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-04-03T09:12:37Z,2020-04-03T09:12:37Z,Diagnostic Test,Online Questionnaire,Online Questionnaire via SoSci Survey,1,Recruiting,CharitÃ©-UniversitÃ¤tsmedizin Berlin - Department of Psychiatry and Psychotherapy,Berlin,,10117,Germany,1
NCT04328454,"ClinicalTrials.gov processed this data on April 02, 2020",2020-03-27,NA,NA,2020-03-30,2020-03-30,2020-03-31,Actual,NA,NA,NA,NA,NA,NA,2020-03-30,2020-03-31,Actual,"January 30, 2020",Actual,2020-01-30,March 2020,2020-03-31,"April 15, 2020",Anticipated,2020-04-15,"April 2, 2020",Anticipated,2020-04-02,NA,Observational,NA,,Clinical Characteristics and Prognostic Factors of Patients With COVID-19,Clinical Characteristics and Prognostic Factors of Patients With COVID-19 in Chibi Hospital of Hubei Province,Recruiting,NA,NA,120,Anticipated,Shanghai 10th People's Hospital,,NA,1,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-04-03T09:14:12Z,2020-04-03T09:14:12Z,Other,retrospective analysis,The investigators retrospectively analyzed the hospitalized patients with COVID-19,1,Recruiting,Shanghai 10th People's Hospital,Shanghai,Shanghai,+86200072,China,1
NCT04327531,"ClinicalTrials.gov processed this data on April 02, 2020",2020-03-27,NA,NA,2020-03-31,2020-03-27,2020-03-31,Actual,NA,NA,NA,NA,NA,NA,2020-03-31,2020-04-02,Estimate,"March 26, 2020",Actual,2020-03-26,March 2020,2020-03-31,"April 28, 2020",Anticipated,2020-04-28,"April 26, 2020",Anticipated,2020-04-26,NA,Observational,NA,,"Evaluation of Covid 19 Knowledge Anxiety and Expectation Levels of Turkish Physicians, Survey Study","Evaluation of Covid 19 Knowledge Anxiety and Expectation Levels of Turkish Physicians, Survey Study","Active, not recruiting",NA,NA,200,Actual,Kanuni Sultan Suleyman Training and Research Hospital,,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-04-03T09:14:48Z,2020-04-03T09:14:48Z,Behavioral,turkish physicians,"turkish physicians, who work active in pandemic hospital.",1,,Pinar Yalcin Bahat,Istanbul,Ä°Ì‡stanbul,34000,Turkey,1
NCT04329546,"ClinicalTrials.gov processed this data on April 02, 2020",2020-03-29,NA,NA,2020-03-29,2020-03-29,2020-04-01,Actual,NA,NA,NA,NA,NA,NA,2020-03-29,2020-04-01,Actual,"March 27, 2020",Actual,2020-03-27,March 2020,2020-03-31,"March 31, 2022",Anticipated,2022-03-31,"January 31, 2022",Anticipated,2022-01-31,NA,Observational,NA,,Understanding COVID,How Immune Responses Shape Virological and Clinical Characteristics of COVID-19: a Prospective Cohort Study,Recruiting,NA,NA,250,Anticipated,"University Hospital, Geneva",,NA,2,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,Samples With DNA,"
      naso- & oro-pharyngeal smears, sputum, blood
    ",NA,NA,NA,Undecided,"Fully anonymized data that are not already published may be shared on reasonable request from a qualified investigator, at the discretion of the Project Leader.",2020-04-03T09:13:33Z,2020-04-03T09:13:33Z,Other,NA (no intervention),NA (no intervention),1,Recruiting,University Hospitals of Geneva,Geneva,,1211,Switzerland,1
NCT04332016,"ClinicalTrials.gov processed this data on April 02, 2020",2020-03-30,NA,NA,2020-04-01,2020-04-01,2020-04-02,Estimate,NA,NA,NA,NA,NA,NA,2020-04-01,2020-04-02,Estimate,April 2020,Anticipated,2020-04-30,March 2020,2020-03-31,March 2023,Anticipated,2023-03-31,March 2023,Anticipated,2023-03-31,NA,Observational,COLCOV19-BX,,COVID-19 Biological Samples Collection,Biological Samples Collection From Patients and Caregivers Treated at Bordeaux University Hospital for Asymptomatic and Symptomatic Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2) Infection (COVID-19).,Not yet recruiting,NA,NA,2000,Anticipated,"University Hospital, Bordeaux",,NA,1,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,Samples With DNA,"
      Whole Blood Sample Upper respiratory sampling Urine and stool collection Post mortem biopsies
    ",NA,NA,NA,No,NA,2020-04-03T09:12:08Z,2020-04-03T09:12:08Z,Other,biological samples collection,"collection of whole blood samples, urine and stool samples, upper respiratory samples, post-mortem biopsies",1,,Centre Hospitalier Universitaire de Bordeaux,Bordeaux,,33076,France,1
NCT04330521,"ClinicalTrials.gov processed this data on April 02, 2020",2020-03-30,NA,NA,2020-03-31,2020-03-31,2020-04-01,Actual,NA,NA,NA,NA,NA,NA,2020-03-31,2020-04-01,Actual,April 2020,Anticipated,2020-04-30,March 2020,2020-03-31,May 2022,Anticipated,2022-05-31,May 2022,Anticipated,2022-05-31,NA,Observational,NA,,Impact of the Coronavirus (COVID-19) on Patients With Cancer,Impact of the Coronavirus (COVID-19) on Patients With Cancer,Not yet recruiting,NA,NA,50,Anticipated,Stanford University,,NA,NA,NA,FALSE,NA,NA,NA,NA,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,NA,2020-04-03T09:12:56Z,2020-04-03T09:12:56Z,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
NCT04331886,"ClinicalTrials.gov processed this data on April 02, 2020",2020-03-31,NA,NA,2020-04-01,2020-04-01,2020-04-02,Estimate,NA,NA,NA,NA,NA,NA,2020-04-01,2020-04-02,Estimate,April 2020,Anticipated,2020-04-30,March 2020,2020-03-31,March 2021,Anticipated,2021-03-31,March 2021,Anticipated,2021-03-31,NA,Observational,COVID-19,,An Observational Study of Patients With Coronavirus Disease 2019,An Observational Study of Patients With Coronavirus Disease 2019,Not yet recruiting,NA,NA,5000,Anticipated,"Target PharmaSolutions, Inc.",,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-04-03T09:12:12Z,2020-04-03T09:12:12Z,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
NCT04331509,"ClinicalTrials.gov processed this data on April 02, 2020",2020-03-31,NA,NA,2020-03-31,2020-03-31,2020-04-02,Estimate,NA,NA,NA,NA,NA,NA,2020-03-31,2020-04-02,Estimate,"March 23, 2020",Actual,2020-03-23,March 2020,2020-03-31,"March 23, 2022",Anticipated,2022-03-23,"March 23, 2022",Anticipated,2022-03-23,NA,Observational,NA,,COVID-19 Symptom Tracker,COVID-19 Symptom Tracker,Recruiting,NA,NA,10000000,Anticipated,King's College London,,NA,1,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,NA,,Immediately,"Request to access the COVID-19 Symptom Tracker data should made by submitting an online Data Access Application Form. The form is available on the TwinsUK website.
https://dtr.eu.qualtrics.com/jfe/form/SV_81U9lmshTofiFeZ
Decision Process & Outcome:
Upon submission of the Covid-19 Data Application Form, the TwinsUK data management team will review the application forms received and information on the outcome will be provided within a week. Decisions on the most complex applications will be overseen by the TwinsUK Resource Executive Committee.
All applicants must belong to the clinical or scientific community, present a valid rationale and must have
A healthcare email address
An educational email address
A track of peer reviewed publications",https://dtr.eu.qualtrics.com/jfe/form/SV_81U9lmshTofiFeZ,Yes,"Access to the COVID-19 Symptom Tracker data will be given to members of the clinical or scientific community as outlined below in accordance with the following privacy policies:
https://covid.joinzoe.com/privacy-notice
https://storage.googleapis.com/covid-symptom-tracker-public/privacy-policy-us.pdf",2020-04-03T09:12:24Z,2020-04-03T09:12:24Z,Other,No Intervention,No Intervention,1,Recruiting|Recruiting,Massachusetts General Hospital|King's College London,Boston|London,Massachusetts|,02114|SE1 7EH,United States|United Kingdom,2
NCT04330599,"ClinicalTrials.gov processed this data on April 02, 2020",2020-03-31,NA,NA,2020-03-31,2020-03-31,2020-04-01,Actual,NA,NA,NA,NA,NA,NA,2020-03-31,2020-04-01,Actual,"April 2, 2020",Anticipated,2020-04-02,March 2020,2020-03-31,"April 1, 2025",Anticipated,2025-04-01,"April 1, 2025",Anticipated,2025-04-01,NA,Observational,COVIDENCE,,Longitudinal Population-based Observational Study of Coronavirus Disease in the UK Population,Longitudinal Population-based Observational Study of Coronavirus Disease in the UK Population,Not yet recruiting,NA,NA,12000,Anticipated,Queen Mary University of London,,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Yes,NA,2020-04-03T09:12:53Z,2020-04-03T09:12:53Z,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
